| abstract |
Disclosed is a class of imidazo[1,2-a]pyridine compounds of formula III as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and prevention, inhibition, or amelioration of one or more diseases associated with cyclin dependent kinases using such compounds or pharmaceutical compositions. The compounds are useful as protein kinase inhibitors in diseases such as cancer, inflammation arthritis, viral diseases, neurodegenerative diseases such as Alzheimer's disease, cardiovascular diseases, and fungal diseases. |